Rifaximin oral tablet ( DrugBank: Rifaximin )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
99	慢性特発性偽性腸閉塞症	1

99. 慢性特発性偽性腸閉塞症

---

臨床試験数 : 4 /  薬物数 : 9 - (DrugBank : 2) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 4

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04118699 (ClinicalTrials.gov)	December 25, 2019	23/9/2019	Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial	Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Single Center, Randomized, Placebo Controlled, Double-blind Phase 2 Trial	Chronic Intestinal Pseudo-obstruction	Drug: Rifaximin oral tablet;Drug: Placebo oral tablet	Yokohama City University	ASKA Pharmaceutical Co., Ltd.	Active, not recruiting	20 Years	74 Years	All	12	Phase 2	Japan